Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.

A specific and sensitive radioimmunoassay for the determination of levels of zalcitabine in human plasma, urine, and cerebrospinal fluid has been developed. Commercially available radiolabel and antiserum (Sigma Chemicals) were used after dilution in assay buffer. Prior to the immunoassay, standard...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Burger, D M, Rosing, H, ten Napel, C H, Duyts, T, Meenhorst, P L, Mulder, J W, Koks, C H, Bult, A, Beijnen, J H
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1994
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188282/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7695259/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.12.2763
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!